Search

Your search keyword '"Alvarez, Alicarmen"' showing total 4 results
Start Over Author "Alvarez, Alicarmen"
4 results on '"Alvarez, Alicarmen"'

1. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial

Author

Butler, Ellie, Winter, Jean, Xu, Jianguo, Sherman, Amy, Kelley, Colleen, Fredrick, Rameses, Rouphael, Nadine, Phadke, Varun, Whitney, Cynthia, Alvarez, Alicarmen, Dennis, Renata, Fineman, Rebecca, Lankford-Turner, Pamela, Yi, Sha, Lai, Lilin, Burch, Gena, Gupta, Shanker, Berkowitz, Nina, Carter, Cristina, Beck, Allison, Larkin, Brenda, Taylor, Stephanie, Alger, Mandy, Bahorich, Jessica, Lynch Chamberlain, Amy, Chang, Ya-chen, Chaudhuri, Rajoshi, Cooper, Jonathan, Demirji, Jacob, Yang, Fan, Fernald, Alissa, Gollapudi, Deepika, Holland-Linn, Janel, Kueltzo, Lisa, Lee, James, Liu, Jie, Liu, Xun, Mowery, Rachel, O'Connell, Sarah, Rosales-Zavala, Erwin, Sands, Jason, Wang, Xin, Weng, Shaojie, Witter, Sara, Coates, Emily E, Edupuganti, Srilatha, Chen, Grace L, Happe, Myra, Strom, Larisa, Widge, Alicia, Florez, Maria Burgos, Cox, Josephine H, Gordon, Ingelise, Plummer, Sarah, Ola, Abidemi, Yamshchikov, Galina, Andrews, Charla, Curate-Ingram, Sharon, Morgan, Patricia, Nagar, Shashi, Collins, Matthew H, Bray, Amy, Nguyen, Thuy, Stein, Judy, Case, Christopher L, Kaltovich, Florence, Wycuff, Diane, Liang, C Jason, Carlton, Kevin, Vazquez, Sandra, Mascola, John R, and Ledgerwood, Julie E

Published
2022
Full Text
View/download PDF

2. Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection

Author

Sandler, Netanya G, Zhang, Xinyan, Bosch, Ronald J, Funderburg, Nicholas T, Choi, Andrew I, Robinson, Janet K, Fine, Derek M, Coombs, Robert W, Jacobson, Jeffrey M, Landay, Alan L, Douek, Daniel C, Tressler, Randall, Read, Sarah W, Wilson, Cara C, Deeks, Steven G, Lederman, Michael M, Gandhi, Rajesh T, Tiu, Jennifer, Janik, Jennifer, Ebiasah, Ruth, Sise, Thucuma, Morse, Gene, Bishopric, George, Klebert, Michael, Borowski, LuAnn, Harding, Paul, Gonzalez, Amy, Tracy, Russell, Claggett, Brian, Alvarez, Alicarmen, James, Tamara, Walton, Patricia, Allen, Kristen, Daar, Eric, Lopez, Ruben, Tebas, Pablo, Thomas, Aleshia, Sbrolla, Amy, Flynn, Teri, Whitely, Kim, Davis, Traci, McGregor, Donna, Taiwo, Babafemi, Hurley, Christine, Lake, Jordan, Luetkemeyer, Annie, Smith, Anna, Fichtenbaum, Carl J, Stockton, Jan M, Griesmer, Kristine, Ray, Graham, Bolivar, Hector H, Fischl, Margaret A, Adams, Mary, Klebert, Michael K, and Royal, Michael

Subjects
HIV/AIDS, Cardiovascular, Infectious Diseases, Clinical Research, Heart Disease, Atherosclerosis, Evaluation of treatments and therapeutic interventions, 2.1 Biological and endogenous factors, 6.1 Pharmaceuticals, Aetiology, Infection, Good Health and Well Being, Adult, Bacterial Translocation, Cardiovascular Agents, Cardiovascular Diseases, Cholesterol, LDL, HIV Infections, Humans, Lipopolysaccharide Receptors, Lipopolysaccharides, Lipoproteins, LDL, Male, Middle Aged, Polyamines, Sevelamer, Thromboplastin, Treatment Outcome, Young Adult, HIV, sevelamer, microbial translocation, LPS, sCD14, soluble tissue factor, LDL, oxLDL, AIDS Clinical Trials Group A5296 Team, Biological Sciences, Medical and Health Sciences, Microbiology
Abstract

UnlabelledAbnormal levels of inflammation are associated with cardiovascular disease and mortality in human immunodeficiency virus (HIV)-infected patients. Microbial translocation, which may cause inflammation, is decreased by sevelamer in patients undergoing hemodialysis. In this single-arm study, we evaluated the effects of 8 weeks of sevelamer therapy on 36 HIV-infected subjects who were not receiving antiretroviral therapy. Sevelamer did not significantly change markers of microbial translocation, inflammation, or T-cell activation. During sevelamer treatment, however, levels of soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol decreased significantly, whereas D-dimer levels increased. Thus, in this study population, sevelamer did not reduce microbial translocation but may have yielded cardiovascular benefits.Clinical trials registrationNCT 01543958.

Published
2014

3. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial

Author

Coates, Emily E, primary, Edupuganti, Srilatha, additional, Chen, Grace L, additional, Happe, Myra, additional, Strom, Larisa, additional, Widge, Alicia, additional, Florez, Maria Burgos, additional, Cox, Josephine H, additional, Gordon, Ingelise, additional, Plummer, Sarah, additional, Ola, Abidemi, additional, Yamshchikov, Galina, additional, Andrews, Charla, additional, Curate-Ingram, Sharon, additional, Morgan, Patricia, additional, Nagar, Shashi, additional, Collins, Matthew H, additional, Bray, Amy, additional, Nguyen, Thuy, additional, Stein, Judy, additional, Case, Christopher L, additional, Kaltovich, Florence, additional, Wycuff, Diane, additional, Liang, C Jason, additional, Carlton, Kevin, additional, Vazquez, Sandra, additional, Mascola, John R, additional, Ledgerwood, Julie E, additional, Butler, Ellie, additional, Winter, Jean, additional, Xu, Jianguo, additional, Sherman, Amy, additional, Kelley, Colleen, additional, Fredrick, Rameses, additional, Rouphael, Nadine, additional, Phadke, Varun, additional, Whitney, Cynthia, additional, Alvarez, Alicarmen, additional, Dennis, Renata, additional, Fineman, Rebecca, additional, Lankford-Turner, Pamela, additional, Yi, Sha, additional, Lai, Lilin, additional, Burch, Gena, additional, Gupta, Shanker, additional, Berkowitz, Nina, additional, Carter, Cristina, additional, Beck, Allison, additional, Larkin, Brenda, additional, Taylor, Stephanie, additional, Alger, Mandy, additional, Bahorich, Jessica, additional, Lynch Chamberlain, Amy, additional, Chang, Ya-chen, additional, Chaudhuri, Rajoshi, additional, Cooper, Jonathan, additional, Demirji, Jacob, additional, Yang, Fan, additional, Fernald, Alissa, additional, Gollapudi, Deepika, additional, Holland-Linn, Janel, additional, Kueltzo, Lisa, additional, Lee, James, additional, Liu, Jie, additional, Liu, Xun, additional, Mowery, Rachel, additional, O'Connell, Sarah, additional, Rosales-Zavala, Erwin, additional, Sands, Jason, additional, Wang, Xin, additional, Weng, Shaojie, additional, and Witter, Sara, additional

Published
2022
Full Text
View/download PDF

4. Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum

Author

Rouphael, Nadine, primary, Beck, Allison, additional, Kirby, Amy E, additional, Liu, Pengbo, additional, Natrajan, Muktha S, additional, Lai, Lilin, additional, Phadke, Varun, additional, Winston, Juton, additional, Raabe, Vanessa, additional, Collins, Matthew H, additional, Girmay, Tigisty, additional, Alvarez, Alicarmen, additional, Beydoun, Nour, additional, Karmali, Vinit, additional, Altieri-Rivera, Joanne, additional, Lindesmith, Lisa C, additional, Anderson, Evan J, additional, Wang, Yuke, additional, El-Khorazaty, Jill, additional, Petrie, Carey, additional, Baric, Ralph S, additional, Baqar, Shahida, additional, Moe, Christine L, additional, and Mulligan, Mark J, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results